2015 ASCO AM Public Monday - ASCO
Powered by SmugMug Log In
Lymphoma Oral Abstract Session

Lymphoma Oral Abstract Session

Chicago, IL - 2015 ASCO Annual Meeting - Laurie Helen Sehn, MDCM, MPH, presenting abstract LBA8502, GADOLIN: Primary results from a phase III study of obinutuzumab plus bendamustine compared with bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma. during Lymphoma Oral Abstract Session at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Monday, June 1, 2015. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the 51st Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Rodney White 2015 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org